![](/img/cover-not-exists.png)
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up a randomised, controlled, phase 3 trial
Mateos, María-Victoria, Hernández, Miguel-Teodoro, Giraldo, Pilar, de la Rubia, Javier, de Arriba, Felipe, Corral, Lucía López, Rosiñol, Laura, Paiva, Bruno, Palomera, Luis, Bargay, Joan, Oriol, AlberLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(16)30124-3
Date:
July, 2016
File:
PDF, 316 KB
english, 2016